A data driven approach to accelerate your programs to the market
We have proven capabilities to develop liquid and lyophilized injectable (or parenteral) DP formulations in various injectable formats including PFS, vials (single-use and multi-use) and cartridges as per regulatory and client requirements. Our data driven approaches to select robust and stable formulations to accelerate the timelines from laboratory to market.
Our capabilities include
- Formulations developed over a broad range of dose concentrations
- Screening of buffers and excipients
- Biosimilar formulations
- Process characterization studies
- Container closure system selection and stability studies to analyse the robustness of the formulation
- Regulatory preparation services
